Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PROSCA/BLADDR 2020 | Challenges and treatment advances in mHSPC

Ursula Vogl, MD, Ente Ospedaliero Cantonale (EOC), Ticino, Switzerland, discusses treatment advances in metastatic hormone-sensitive prostate cancer (mHSPC) as well as the impact of COVID-19 on treatment approaches. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).